Market Research Logo

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2018

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2018 provides an overview of Female Fertility Rapid Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Female Fertility Rapid Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Female Fertility Rapid Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Female Fertility Rapid Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Female Fertility Rapid Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Female Fertility Rapid Tests Overview
3 Products under Development
3.1 Female Fertility Rapid Tests - Pipeline Products by Stage of Development
3.2 Female Fertility Rapid Tests - Pipeline Products by Segment
3.3 Female Fertility Rapid Tests - Pipeline Products by Territory
3.4 Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
3.5 Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date
4 Female Fertility Rapid Tests - Pipeline Products under Development by Companies
4.1 Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development
4.2 Female Fertility Rapid Tests - Pipeline Products by Stage of Development
5 Female Fertility Rapid Tests Companies and Product Overview
5.1 BBB Technologies Inc Company Overview
5.1.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Bio-Alternative Medical Devices Ltd Company Overview
5.2.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 ET Healthcare, Inc. Company Overview
5.3.1 ET Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 NG Biotech Company Overview
5.4.1 NG Biotech Pipeline Products & Ongoing Clinical Trials Overview
5.5 OPKO Health Inc Company Overview
5.5.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Pop Test LLC Company Overview
5.6.1 Pop Test LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Quidel Corp Company Overview
5.7.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
6 Female Fertility Rapid Tests- Recent Developments
6.1 Jun 22, 2018: Bob Schruender, CEO Joins Sekisui Medical Board of Directors
6.2 Jun 14, 2018: FIRST TO KNOW Whole Blood, Rapid Pregnancy Test from NOW Diagnostics Available Over-The-Counter in Italy
6.3 May 08, 2018: Quidel Announces First Quarter 2018 Financial Results
6.4 Apr 25, 2018: NanoRepro Increases Sales and Achieves Positive Operating Result (EBITDA)
6.5 Apr 10, 2018: NanoRepro Reaches Its Annual Targets and Wants to Grow Strongly in 2018
6.6 Feb 21, 2018: Quidel Reports Fourth Quarter and Full Year 2017 Financial Results
6.7 Feb 19, 2018: Quidel to establish new Business Service Centre in Galway city
6.8 Dec 05, 2017: Lia Diagnostics Announces FDA Clearance Of The First And Only Flushable, Biodegradable Pregnancy Test
6.9 Dec 05, 2017: NanoRepro With Higher Sales and Better Results
6.10 Nov 01, 2017: Quidel Reports Third Quarter 2017 Financial Results
6.11 Oct 11, 2017: Aided by provincial government, Sekisui completes renovation and announces expansion
6.12 Sep 29, 2017: Alere Announces the U.S. Department of Justice Closes Investigation
6.13 Sep 28, 2017: Alere Announces Settlement with SEC
6.14 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results
6.15 Aug 03, 2017: NanoRepro Increases Growth in the Second Quarter
6.16 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Table 2: Female Fertility Rapid Tests - Pipeline Products by Segment
Table 3: Female Fertility Rapid Tests - Pipeline Products by Territory
Table 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
Table 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date
Table 6: Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development
Table 7: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Table 8: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Mobile RDT Reader - Alpha-fetoprotein Test - Product Status
Table 10: Mobile RDT Reader - Alpha-fetoprotein Test - Product Description
Table 11: Mobile RDT Reader - FSH Test - Product Status
Table 12: Mobile RDT Reader - FSH Test - Product Description
Table 13: Mobile RDT Reader - Luteinizing Hormone Test - Product Status
Table 14: Mobile RDT Reader - Luteinizing Hormone Test - Product Description
Table 15: Mobile RDT Reader - Serum/Urine Based HCG Test - Product Status
Table 16: Mobile RDT Reader - Serum/Urine Based HCG Test - Product Description
Table 17: Mobile RDT Reader - Urine Based HCG Test - Product Status
Table 18: Mobile RDT Reader - Urine Based HCG Test - Product Description
Table 19: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Digital Strip Reader - Fertility - Product Status
Table 21: Digital Strip Reader - Fertility - Product Description
Table 22: Digital Strip Reader - Pregnancy Testing - Product Status
Table 23: Digital Strip Reader - Pregnancy Testing - Product Description
Table 24: ET Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Pylon Assay - Estrogen - Product Status
Table 26: Pylon Assay - Estrogen - Product Description
Table 27: Pylon Assay - Follicle Stimulating Hormone - Product Status
Table 28: Pylon Assay - Follicle Stimulating Hormone - Product Description
Table 29: Pylon Assay - Luteinizing Hormone - Product Status
Table 30: Pylon Assay - Luteinizing Hormone - Product Description
Table 31: Pylon Assay - Progesterone - Product Status
Table 32: Pylon Assay - Progesterone - Product Description
Table 33: Pylon Assay - Prolactin - Product Status
Table 34: Pylon Assay - Prolactin - Product Description
Table 35: NG Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 36: BB-Blood Precision hCG Test - OTC - Product Status
Table 37: BB-Blood Precision hCG Test - OTC - Product Description
Table 38: hCG Monitor - Product Status
Table 39: hCG Monitor - Product Description
Table 40: NG-Quant hCG - Product Status
Table 41: NG-Quant hCG - Product Description
Table 42: NG-Test hCG Pregnancy Termination - Product Status
Table 43: NG-Test hCG Pregnancy Termination - Product Description
Table 44: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Diagnostic Assay - Fertility - Product Status
Table 46: Diagnostic Assay - Fertility - Product Description
Table 47: Pop Test LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Pregnancy Pop Test - Product Status
Table 49: Pregnancy Pop Test - Product Description
Table 50: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Sofia hCG Quant Assay - Product Status
Table 52: Sofia hCG Quant Assay - Product Description
Table 53: Glossary
1.2 List of Figures
Figure 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Figure 2: Female Fertility Rapid Tests - Pipeline Products by Segment
Figure 3: Female Fertility Rapid Tests - Pipeline Products by Territory
Figure 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
Figure 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report